Tangtang Xiang

Key Laboratory Of Post Neuro Injury Neuro Repair And Regeneration In Central Nervous System, State Key Laboratory Of Experimental Hematology, Ministry Of Education
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Fingolimod improves diffuse brain injury by promoting AQP4 polarization and functional recovery of the glymphatic system.

Fingolimod improves diffuse brain injury by promoting AQP4 polarization and functional recovery of the glymphatic system.

Journal: CNS neuroscience & therapeutics

Published: October 23, 2023

Inactivation of ERK1/2 signaling mediates dysfunction of basal meningeal lymphatic vessels in experimental subdural hematoma.

Inactivation of ERK1/2 signaling mediates dysfunction of basal meningeal lymphatic vessels in experimental subdural hematoma.

Journal: Theranostics

Published: June 30, 2023

Effects of increased intracranial pressure on cerebrospinal fluid influx, cerebral vascular hemodynamic indexes, and cerebrospinal fluid lymphatic efflux.

Effects of increased intracranial pressure on cerebrospinal fluid influx, cerebral vascular hemodynamic indexes, and cerebrospinal fluid lymphatic efflux.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: August 13, 2022

The inflammatory cellular feature in the peripheral blood of chronic subdural hematoma patients.

The inflammatory cellular feature in the peripheral blood of chronic subdural hematoma patients.

Journal: Journal of clinical laboratory analysis

Published: June 02, 2022

Possible mechanism and Atorvastatin-based treatment in cupping therapy-related subdural hematoma: A case report and literature review.

Possible mechanism and Atorvastatin-based treatment in cupping therapy-related subdural hematoma: A case report and literature review.

Journal: Frontiers in neurology

Published: March 20, 2022

Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis.

Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis.

Journal: Frontiers in aging neuroscience

Published: June 17, 2021

Dexamethasone enhances the efficacy of atorvastatin in inhibiting excessively inflammation-induced abnormal angiogenesis by regulating macrophages.

Dexamethasone enhances the efficacy of atorvastatin in inhibiting excessively inflammation-induced abnormal angiogenesis by regulating macrophages.

Journal: Journal of neuroinflammation

Published: March 17, 2021

Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases.

Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases.

Journal: Frontiers in oncology

Published: March 08, 2021

Subdural haematomas drain into the extracranial lymphatic system through the meningeal lymphatic vessels.

Subdural haematomas drain into the extracranial lymphatic system through the meningeal lymphatic vessels.

Journal: Acta neuropathologica communications

Published: December 02, 2019

Hematoma-derived exosomes of chronic subdural hematoma promote abnormal angiogenesis and inhibit hematoma absorption through miR-144-5p.

Hematoma-derived exosomes of chronic subdural hematoma promote abnormal angiogenesis and inhibit hematoma absorption through miR-144-5p.

Journal: Aging

Published: September 15, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026